ISIS PHARMACEUTICALS INC 4
4 · ISIS PHARMACEUTICALS INC · Filed Jul 3, 2007
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Other
Common Stock
2007-07-01$8.23/sh+902$7,422→ 7,505 total - Sale
Common Stock
2007-07-02$9.70/sh−902$8,752→ 6,603 total
Footnotes (2)
- [F1]Reporting 902 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on July 1, 2007.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/28/07.